First Time Loading...

Destiny Pharma PLC
LSE:DEST

Watchlist Manager
Destiny Pharma PLC Logo
Destiny Pharma PLC
LSE:DEST
Watchlist
Price: 15.75 GBX Market Closed
Updated: Jun 1, 2024

Destiny Pharma PLC
Common Shares Outstanding

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Destiny Pharma PLC
Common Shares Outstanding Peer Comparison

Comparables:
CNTA
AUTL
BCYC
IMCR
GNS

Competitive Common Shares Outstanding Analysis
Latest Figures & CAGR of Competitors

Company Common Shares Outstanding CAGR 3Y CAGR 5Y CAGR 10Y
Destiny Pharma PLC
LSE:DEST
Common Shares Outstanding
£95.3m
CAGR 3-Years
17%
CAGR 5-Years
17%
CAGR 10-Years
N/A
Centessa Pharmaceuticals PLC
NASDAQ:CNTA
Common Shares Outstanding
$98.8m
CAGR 3-Years
4%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Autolus Therapeutics PLC
NASDAQ:AUTL
Common Shares Outstanding
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Bicycle Therapeutics PLC
NASDAQ:BCYC
Common Shares Outstanding
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Immunocore Holdings PLC
NASDAQ:IMCR
Common Shares Outstanding
£49.7m
CAGR 3-Years
6%
CAGR 5-Years
3%
CAGR 10-Years
N/A
Genus PLC
LSE:GNS
Common Shares Outstanding
£66m
CAGR 3-Years
0%
CAGR 5-Years
0%
CAGR 10-Years
1%

See Also

What is Destiny Pharma PLC's Common Shares Outstanding?
Common Shares Outstanding
95.3m GBP

Based on the financial report for Dec 31, 2023, Destiny Pharma PLC's Common Shares Outstanding amounts to 95.3m GBP.

What is Destiny Pharma PLC's Common Shares Outstanding growth rate?
Common Shares Outstanding CAGR 5Y
17%

Over the last year, the Common Shares Outstanding growth was 30%. The average annual Common Shares Outstanding growth rates for Destiny Pharma PLC have been 17% over the past three years , 17% over the past five years .